mybacs is a Swiss pharma company with offices in Zug and Munich. At mybacs the focus lies on the human microbiome and the development of highly dosed, state of the art synbiotic supplements.
Travelbacs - the first mybacs product was launched in February 2019. Travelbacs is a synbiotic compound which was specifically adapted to the pathogenic profile of certain travel regions. Its aim is to reduce the strains of traveling to these regions by preparing the digestive tract using a highly dosed supplement containing carefully selected probiotic strains combined with prebiotic Inulin to improve the supplements efficiency.
mybacs is a quality driven company that believes in living up to the highest possible standards in the probiotic field. At mybacs we will always put product and customer first. All mybacs products are based on peer reviewed, independent studies.